Articles by Ben Bonifant - Pharmaceutical Executive

ADVERTISEMENT

Articles by Ben Bonifant

Ben Bonifant


Ben Bonifant is a vice-president of Mercer Management Consulting, based in Washington, D.C.

Articles
Test and Learn: Making Confident Decisions on the Commercial Side
March 1, 2013

Companies that adopt this new methodology will have a longstanding competitive advantage over those companies conducting business as usual.

The Shakeout
May 1, 2009

When it comes to licensing in this market, there are winners and losers. Learn the new rules of the game.

Driven to License
February 1, 2007

Goodbye, M&As. Hello, L&As. The new trend in business development is licensing deals and acquisitions. The hot categories are CNS, oncology, and immunology. Now let's get bizzy.

New Playing Fields
September 1, 2001

For the past 20 years, the blockbuster model has dominated the pharmaceutical industry. It has generated tremendous value for companies and shareholders and will likely continue to do so well into the future. That business design matched Big Pharma's expansive product development and marketing investments with the ample supply of opportunities for benefiting large patient populations and allowed an unusually large number of players to succeed in the high-stakes game. Not all companies can continue to win that game, however, so new fields of competition will be needed.

ADVERTISEMENT

Click here